Personensuche
Personensuche
Es wurde 1 Person gefunden.
Telefon
Funktionen
-
Direktor/in, Klinik für Strahlentherapie
Aktuelle Veranstaltungen
-
SoSe 2025
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen für höhere Semester (mit Patientenvorstellung) (PV)
- Der radiologische Fall der Woche: Bildbeispiele, Indikationen und Grundlagen (*)
- Praktische Tumormodelle in der Strahlentherapie (*)
- Wahlfach für den 1. Studienabschnitt: Einführung in die Grundlagen der Strahlentherapie
- Radiologische Klinik für den 2. Studienabschnitt: Radiologische Onkologie mit Patientenvorstellung (*)
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen (Nuklearmedizin und Strahlentherapie) für höhere Semester (mit Patientenvorstellung) (*)
- Klinische Visite (*)
- Bestrahlungsplanung mit Fallbeispielen. Neue Entwicklung in der konformalen Strahlentherapie (*)
- Ringvorlesung: Tumordiagnostik (mit Patientenvorstellung) (*)
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (PV)
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil I (WA) (begleitende Vorlesung zum Kurs)
- Vorlesung des GRK 1739 (mit Gastsprechern)
- Öffentliches Tumorboard Lungenkrebszentrum
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Strahlentherapie (WA)
- Endokrines Tumorzentrum am WTZ und ENETS-Center of Excellence
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (WA) begleitende Vorlesung zum Kurs
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil I (PV)
- Brachy-Strahlentherapie (*)
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil III (PV)
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
- Radiologische Klinik für den 2. Studienabschnitt: Radiologische Onkologie mit Patientenvorstellung (*)
- Der radiologische Fall der Woche: Bildbeispiele, Indikationen und Grundlagen (*)
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (PV)
- Praktische Tumormodelle in der Strahlentherapie (*)
- Klinische Visite (*)
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen (Nuklearmedizin und Strahlentherapie) für höhere Semester (mit Patientenvorstellung) (*)
- Wahlfach für den 1. Studienabschnitt: Einführung in die Grundlagen der Strahlentherapie
- Bestrahlungsplanung mit Fallbeispielen. Neue Entwicklung in der konformalen Strahlentherapie (*)
- Ringvorlesung: Tumordiagnostik (mit Patientenvorstellung) (*)
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil III (PV)
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Are treatment plans optimized on the basis of acuros XB dose calculation robust against anatomic changes during online adaptive radiotherapy for lung cancer regarding dose homogeneity?In: Radiation Oncology , Jg. 20 2025, Nr. 1, 75DOI (Open Access)
-
Behandlungsbedingte Komplikationen und funktionelle Ergebnisse nach Ruthenium-106-Brachytherapie bei kleinen bis mittelgroßen Aderhautmelanomen (Teil 2)In: Klinische Monatsblätter für Augenheilkunde , Jg. 242 2025, Nr. 2, S. 116 – 126
-
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceIn: Nature Cancer , Jg. 6 2025, Nr. 2, S. 307 – 322DOI (Open Access)
-
Definitive Radiochemotherapie des Ösophaguskarzinoms: : etablierte Therapie und neue StandardsIn: Die Onkologie , Jg. 31 2025, S. 174 – 181
-
Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanomaIn: Radiotherapy and Oncology (The Green Journal) , Jg. 205 2025, 110775DOI (Open Access)
-
Functional outcome after Brachytherapy with bi-nuclide (Ru-106/Iodine-125) plaques in large uveal melanomasIn: Radiation Oncology , Jg. 20 2025, Nr. 1, 22DOI (Open Access)
-
Head-to-head comparison of ⁶⁸ Ga-FAPI-46 PET/CT, ¹⁸F-FDG PET/CT, and contrast-enhanced CT for the detection of various tumorsIn: Annals of Nuclear Medicine , Jg. 39 2025, Nr. 3, S. 255 – 265
-
Multimodal chemoradiotherapy including interstitial brachytherapy enhances outcomes in FIGO stage IVA cervical cancer : A focus on tumor control and quality of lifeIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics 2025 , in pressDOI (Open Access)
-
Oligometastatic non-small cell lung cancer : Impact of local and contemporary systemic treatment approaches on clinical outcomeIn: International Journal of Cancer , Jg. 156 2025, Nr. 4, S. 776 – 787DOI (Open Access)
-
Pre-treatment anemia in head and neck cancer : risk factors, subtypes, and survival outcomesIn: Frontiers in Oncology , Jg. 15 2025, 1577901DOI (Open Access)
-
Prognostic factors for surgical treatment of radiation-induced scleral necrosis after brachytherapy for uveal melanomaIn: European Journal of Ophthalmology , Jg. 35 2025, Nr. 1, S. 357 – 366DOI (Open Access)
-
Radiopharmaceuticals in Prostate Cancer : General Considerations and Utility in Combination With EBRTIn: Seminars in Radiation Oncology , Jg. 35 2025, Nr. 3, S. 463 – 473
-
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer MembersIn: International Journal of Radiation Oncology, Biology, Physics , Jg. 121 2025, Nr. 4, S. 1006 – 1010DOI (Open Access)
-
Reversing regulatory safeguards : Targeting the ATR pathway to overcome PARP inhibitor resistanceIn: Molecular Therapy Oncology , Jg. 33 2025, Nr. 1, 200934DOI (Open Access)
-
Ruthenium-106-Brachytherapy for the Treatment of Ocular MedulloepitheliomaIn: Ocular Oncology and Pathology 2025 , in press
-
Survivorship program including long-term toxicities and quality-of-life development over 10 years in a randomized trial in operable stage III non-small-cell lung cancer (ESPATUE)In: International Journal of Cancer , Jg. 156 2025, Nr. 1, S. 154 – 163DOI (Open Access)
-
The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitisIn: Translational Lung Cancer Research , Jg. 14 2025, Nr. 6, S. 2074 – 2088DOI (Open Access)
-
C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapyIn: Scientific Reports , Jg. 14 2024, Nr. 1, 13765DOI, Online Volltext (Open Access)
-
Chest wall resections for advanced breast cancer : a narrative reviewIn: Journal of Thoracic Disease , Jg. 16 2024, Nr. 10, S. 7182 – 7191DOI (Open Access)
-
Defining the role of Tip60 in the DNA damage response of glioma cell linesIn: International Journal of Radiation Biology (RAB) , Jg. 100 2024, Nr. 12, S. 1622 – 1632DOI (Open Access)
-
Diagnostic Accuracy of ⁶⁸Ga-FAPI Versus ¹⁸F-FDG PET in Patients with Various MalignanciesIn: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 3, S. 372 – 378DOI (Open Access)
-
Experimental Examination of Conventional, Semi-Automatic, and Automatic Volumetry Tools for Segmentation of Pulmonary Nodules in a Phantom StudyIn: Diagnostics , Jg. 14 2024, Nr. 1, 28DOI (Open Access)
-
Fibroblast Activation Protein-Directed Imaging Outperforms ¹⁸F-FDG PET/CT in Malignant Mesothelioma : A Prospective, Single-Center, Observational TrialIn: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 8, S. 1188 – 1193
-
Impact of ¹⁸F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer : Results from a Prospective Double-Center TrialIn: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 12, S. 1855 – 1861
-
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment : Comparison with Stage III DiseaseIn: Cancers , Jg. 16 2024, Nr. 6, 1174DOI (Open Access)
-
Prognostic Implications of ⁶⁸Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid TumorsIn: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 7, S. 1027 – 1034
-
Prospects for online adaptive radiation therapy (ART) for head and neck cancerIn: Radiation Oncology , Jg. 19 2024, Nr. 1, 4DOI (Open Access)
-
Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)In: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 7, S. 1076 – 1079
-
Recurrent prostate cancer : combined role for MRI and PSMA-PET in ⁶⁸Ga-PSMA-11 PET/MRIIn: European Radiology , Jg. 34 2024, Nr. 7, S. 4789 – 4800DOI (Open Access)
-
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus : Version 4.0 – Dezember 2023 – Registrierungsdatum: 021/023OLIn: Zeitschrift für Gastroenterologie , Jg. 62 2024, Nr. 4, S. 535 – 642DOI (Open Access)
-
Surgical Outcome After Treatment of Radiation-Induced Scleral Necrosis in Patients With Uveal MelanomaIn: Cornea , Jg. 43 2024, Nr. 11, S. 1375 – 1382
-
Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibitionIn: Radiotherapy and Oncology (The Green Journal) , Jg. 200 2024, 110475DOI (Open Access)
-
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival DataIn: Journal of Nuclear Medicine (JNM) , Jg. 65 2024, Nr. 8, S. 1217 – 1223
-
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC : Robust gene signature correlates with radiotherapy outcome in patients and xenograftsIn: Radiotherapy and Oncology (The Green Journal) , Jg. 191 2024, 110055DOI (Open Access)
-
Theranostics with somatostatin receptor antagonists in SCLC : Correlation of 68Ga-SSO120 PET with immunohistochemistry and survivalIn: Theranostics , Jg. 14 2024, Nr. 14, S. 5400 – 5412DOI, Online Volltext (Open Access)
-
68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients : A Single-Center Retrospective StudyIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 10, S. 1540 – 1549DOI (Open Access)
-
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancerIn: Asian Cardiovascular and Thoracic Annals , Jg. 31 2023, Nr. 6, S. 506 – 511DOI (Open Access)
-
Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder CancerIn: Cancers , Jg. 15 2023, Nr. 23, 5629DOI (Open Access)
-
Brachytherapy as a curative option for ocular surface squamous neoplasiaIn: International Ophthalmology , Jg. 43 2023, Nr. 6, S. 1861 – 1865
-
Chemical Inhibition of RPA by HAMNO Alters Cell Cycle Dynamics by Impeding DNA Replication and G2-to-M Transition but Has Little Effect on the Radiation-Induced DNA Damage ResponseIn: International Journal of Molecular Sciences (IJMS) , Jg. 24 2023, Nr. 19, 14941DOI, Online Volltext (Open Access)
-
Combined radiation- and immune checkpoint-inhibitor-induced pneumonitis : The challenge to predict and detect overlapping immune-related adverse effects from evolving laboratory biomarkers and clinical imagingIn: Neoplasia: An International Journal for Oncology Research , Jg. 39 2023, 100892DOI (Open Access)
-
Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume MarginIn: JAMA Network Open , Jg. 6 2023, Nr. 3, S. e234066DOI (Open Access)
-
DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary RadiochemotherapyIn: Clinical Cancer Research , Jg. 29 2023, Nr. 16, S. 3051 – 3064DOI (Open Access)
-
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world settingIn: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 11, S. 9243 – 9252DOI (Open Access)
-
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastomaIn: Neuro-Oncology Advances , Jg. 5 2023, Nr. 1, vdad090DOI, Online Volltext (Open Access)
-
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 5, S. 711 – 716DOI (Open Access)
-
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer : Answers from a Prospective RegistryIn: Cancers , Jg. 15 2023, Nr. 20, 4933DOI (Open Access)
-
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapyIn: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 8, S. 4315 – 4325DOI (Open Access)
-
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on PrognosisIn: Cancers , Jg. 15 2023, Nr. 11, 2982DOI (Open Access)
-
Long-Term Follow-Up of Patients with Conjunctival Lymphoma after Individualized Lens-Sparing Electron Radiotherapy : Results from a Longitudinal StudyIn: Cancers , Jg. 15 2023, Nr. 22, 5433DOI (Open Access)
-
Low CDK Activity and Enhanced Degradation by APC/CCDH¹ Abolishes CtIP Activity and Alt-EJ in Quiescent CellsIn: Cells , Jg. 12 2023, Nr. 11, 1530DOI (Open Access)
-
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy : imaging remission criteria and volumetric regression kineticsIn: Scientific Reports , Jg. 13 2023, Nr. 1, 4792DOI, Online Volltext (Open Access)
-
Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer : The additional value of geometric over dosimetric parameters aloneIn: Frontiers in Oncology , Jg. 12 2023, 870432DOI, Online Volltext (Open Access)
-
New Facets of DNA Double Strand Break Repair : Radiation Dose as Key Determinant of HR versus c-NHEJ EngagementIn: International Journal of Molecular Sciences (IJMS) , Jg. 24 2023, Nr. 19, 14956DOI, Online Volltext (Open Access)
-
Personalized Treatment for Patients With Lung CancerIn: Deutsches Ärzteblatt international , Jg. 120 2023, Nr. 17, S. 300 – 310DOI (Open Access)
-
Pneumonectomy for Primary Lung Tumors and Pulmonary Metastases : A Comprehensive Study of Postoperative Morbidity, Early Mortality, and Preoperative Clinical Prognostic FactorsIn: Current Oncology , Jg. 30 2023, Nr. 11, S. 9458 – 9474DOI, Online Volltext (Open Access)
-
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapyIn: Radiotherapy and Oncology (The Green Journal) , Jg. 183 2023, 109580
-
Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent gliomaIn: Journal of Cancer Research and Clinical Oncology , Jg. 149 2023, Nr. 7, S. 3513 – 3526DOI (Open Access)
-
Preoperative PET-SUVmax and volume based PET parameters of the primary tumor fail to predict nodal upstaging in early-stage lung cancerIn: Lung Cancer , Jg. 176 2023, S. 82 – 88
-
Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication PlatformIn: European Journal of Epidemiology , Jg. 38 2023, Nr. 5, S. 573 – 586DOI (Open Access)
-
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms : Interdisziplinäre S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Krebsgesellschaft – KurzfassungIn: Pneumologie , Jg. 77 2023, Nr. 10, S. 671 – 813DOI (Open Access)
-
Respiration-controlled radiotherapy in lung cancer : Systematic evaluation of the optimal application practiceIn: Clinical and Translational Radiation Oncology , Jg. 40 2023, 100628DOI, Online Volltext (Open Access)
-
SUVmₐₓ Above 20 in ¹⁸F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown PrimaryIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 8, S. 1191 – 1194DOI (Open Access)
-
Telemedicine in Neuro-Oncology : An Evaluation of Remote Consultations during the COVID-19 PandemicIn: Cancers , Jg. 15 2023, Nr. 16, 4054DOI (Open Access)
-
The p38/MK2 Pathway Functions as Chk1-Backup Downstream of ATM/ATR in G₂-Checkpoint Activation in Cells Exposed to Ionizing RadiationIn: Cells , Jg. 12 2023, Nr. 10, 1387DOI (Open Access)
-
Unspecific ¹⁸F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate CancerIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. 5, S. 738 – 743DOI (Open Access)
-
A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORTIn: Cancers , Jg. 14 2022, Nr. 12, 3031DOI (Open Access)
-
ATR Contributes More Than ATM in Intra-S-Phase Checkpoint Activation after IR, and DNA-PKcs Facilitates Recovery : Evidence for Modular Integration of ATM/ATR/DNA-PKcs FunctionsIn: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 14, 7506DOI, Online Volltext (Open Access)
-
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapyIn: Radiotherapy and Oncology (The Green Journal) , Jg. 167 2022, S. 300 – 307
-
BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: : Mechanisms and Potential in Radiation TherapyIn: Cancers , Jg. 14 2022, Nr. 22, 5619DOI, Online Volltext (Open Access)
-
Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC – Hypothesis generation on a multicentre cohort of the DKTK-ROGIn: Radiotherapy and Oncology (The Green Journal) , Jg. 169 2022, S. 8 – 14
-
Breast Radiation Exposure of 3D Digital Breast Tomosynthesis Compared to Full-Field Digital Mammography in a Clinical Follow-Up SettingIn: Diagnostics , Jg. 12 2022, Nr. 2, 456DOI, Online Volltext (Open Access)
-
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitorsIn: Journal of the European Academy of Dermatology and Venereology , Jg. 36 2022, Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 – 44DOI (Open Access)
-
Combination of brachytherapy and intravitreal chemotherapy in the treatment of retinoblastoma with vitreous seedingIn: Ocular Oncology and Pathology , Jg. 8 2022, Nr. 1, S. 64 – 70DOI (Open Access)
-
DNA Damage Clustering after Ionizing Radiation and Consequences in the Processing of Chromatin BreaksIn: Molecules: A Journal of Synthetic Chemistry and Natural Product Chemistry , Jg. 27 2022, Nr. 5, 1540DOI (Open Access)
-
Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapyIn: Radiotherapy and Oncology (The Green Journal) , Jg. 171 2022, S. 91 – 100
-
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factorsIn: Immunotherapy , Jg. 14 2022, Nr. 12, S. 927 – 944DOI (Open Access)
-
Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer : A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG)In: Radiotherapy and Oncology (The Green Journal) , Jg. 167 2022, S. 233 – 238
-
Feasibility, Method and Early Outcome of Image-Guided Volumetric Modulated Arc Radiosurgery Followed by Resection for AJCC Stage IIA–IIIB High-Risk Large Intraocular MelanomaIn: Cancers , Jg. 14 2022, Nr. 19, 4729DOI, Online Volltext (Open Access)
-
First multicentric real-life experience with the combination of CCNU and temozolomide in newly diagnosed MGMT promoter methylated IDH wildtype glioblastomaIn: Neuro-Oncology Advances , Jg. 4 2022, Nr. 1, S. vdac137DOI (Open Access)
-
Increased Gene Targeting in Hyper-Recombinogenic LymphoBlastoid Cell Lines Leaves Unchanged DSB Processing by Homologous RecombinationIn: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 16, 9180DOI, Online Volltext (Open Access)
-
Increased Resection at DSBs in G₂-Phase Is a Unique Phenotype Associated with DNA-PKcs Defects That Is Not Shared by Other Factors of c-NHEJIn: Cells , Jg. 11 2022, Nr. 13, 2099DOI, Online Volltext (Open Access)
-
Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCCIn: Scientific Reports , Jg. 12 2022, Nr. 1, 16755DOI (Open Access)
-
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer PatientsIn: Cancers , Jg. 14 2022, Nr. 15, 3745DOI (Open Access)
-
Long-Term Results after Intraocular Surgery in Treated Retinoblastoma EyesIn: Ocular Oncology and Pathology , Jg. 8 2022, Nr. 3, S. 161 – 167DOI (Open Access)
-
Long-term follow-up and health-related quality of life among cancer survivors with stage IEA orbital-type lymphoma after external photon-beam radiotherapy : Results from a longitudinal studyIn: Hematological Oncology , Jg. 40 2022, Nr. 5, S. 922 – 929DOI (Open Access)
-
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentIn: Radiation Oncology , Jg. 17 2022, Nr. 1, 126DOI, Online Volltext (Open Access)
-
PTEN Loss Enhances Error-Prone DSB Processing and Tumor Cell Radiosensitivity by Suppressing RAD51 Expression and Homologous RecombinationIn: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 21, 12876DOI (Open Access)
-
Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CTIn: Scientific Reports , Jg. 12 2022, Nr. 1, 17511DOI, Online Volltext (Open Access)
-
Scleral complications of plaque brachytherapy for pterygium and for uveal melanoma : ResponseIn: Clinical & Experimental Ophthalmology , Jg. 50 2022, Nr. 4, S. 466 – 467
-
Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapyIn: Frontiers in Oncology , Jg. 12 2022, 999626DOI, Online Volltext (Open Access)
-
Shift in g₁-checkpoint from atm-alone to a cooperative atm plus atr regulation with increasing dose of radiationIn: Cells , Jg. 11 2022, Nr. 1, 63DOI (Open Access)
-
The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with RadiationIn: Cancers , Jg. 14 2022, Nr. 13, 3097DOI, Online Volltext (Open Access)
-
The high toxicity of DSB-clusters modelling high-LET-DNA damage derives from inhibition of c-NHEJ and promotion of alt-EJ and SSA despite increases in HRIn: Frontiers in Cell and Developmental Biology , Jg. 10 2022, 1016951DOI (Open Access)
-
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapyIn: International Journal of Cancer , Jg. 150 2022, Nr. 4, S. 603 – 616DOI (Open Access)
-
⁶⁸Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomasIn: Scientific Reports , Jg. 12 2022, Nr. 1, 16261DOI, Online Volltext (Open Access)
-
Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer : Concurrent Evolvement of PTEN and MEK1 MutationsIn: Clinical Lung Cancer , Jg. 22 2021, Nr. 5, S. E668 – E672
-
Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaksIn: Mutation Research / Genetic Toxicology and Environmental Mutagenesis , Jg. 867 2021, 503372
-
Antitumor immune response is associated with favorable survival in GEP-NEN G3In: Endocrine-Related Cancer , Jg. 28 2021, Nr. 10, S. 683 – 693
-
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapyIn: European Journal of Cancer (EJC) , Jg. 149 2021, S. 211 – 221
-
Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau DiseaseIn: Klinische Monatsblätter für Augenheilkunde , Jg. 238 2021, Nr. 7, S. 781 – 786
-
Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodelingIn: Journal of Nuclear Cardiology , Jg. 28 2021, Nr. 3, S. 812 – 821DOI (Open Access)
-
Case Report : Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant MelanomaIn: Frontiers in Oncology , Jg. 11 2021, S. 637185DOI, Online Volltext (Open Access)
-
Chaetocin induced chromatin condensation : Effect on DNA repair signaling and survivalIn: International Journal of Radiation Biology (RAB) , Jg. 97 2021, Nr. 4, S. 494 – 506
-
Comparison of the intergroup Variation of the Diaphragm-Position in the respiratory triggered CBCT with the Planning-4D-CT as a Basis for the Breath Coaching and Dose AccumulationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 39 – S40
-
Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyIn: The Pharmacogenomics Journal , Jg. 21 2021, Nr. 2, S. 273DOI (Open Access)
-
Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastomaIn: Clinical Neurology and Neurosurgery , Jg. 200 2021, 106348
-
Disruption of chromatin dynamics by hypotonic stress suppresses hr and shifts dsb processing to error-prone ssaIn: International Journal of Molecular Sciences (IJMS) , Jg. 22 2021, Nr. 20, 10957DOI, Online Volltext (Open Access)
-
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trialIn: Radiation Oncology , Jg. 16 2021, Nr. 1, S. 59DOI, Online Volltext (Open Access)
-
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF-phase I/II trialIn: Journal of Applied Clinical Medical Physics , Jg. 22 2021, Nr. 1, S. 242 – 250DOI, Online Volltext (Open Access)
-
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyIn: The Pharmacogenomics Journal , Jg. 21 2021, Nr. 1, S. 37 – 46DOI (Open Access)
-
Electrochemotherapy with bleomycin enhances radiosensitivity of uveal melanomas : First in vitro results in 3d cultures of primary uveal melanoma cell linesIn: Cancers , Jg. 13 2021, Nr. 12, 3086DOI (Open Access)
-
Elektive Strahlentherapie pelviner Lymphknoten beim High-risk-Prostatakarzinom? : Bewertung der Relation zwischen der relativen Risikoreduktion eines PSA-Rezidivs (prostataspezifisches Antigen) innerhalb von 5 Jahren und einem absoluten ÜberlebensvorteilIn: Der Urologe , Jg. 60 2021, Nr. 8, S. 1051 – 1053
-
Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment : assessment of local diagnostic reference levels as a function of age, sex, and interventional successIn: Neuroradiology , Jg. 63 2021, Nr. 3, S. 391 – 398DOI (Open Access)
-
How about levetiracetam in glioblastoma? An institutional experience and meta‐analysisIn: Cancers , Jg. 13 2021, Nr. 15, 3770DOI, Online Volltext (Open Access)
-
Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including CetuximabIn: Frontiers in Oncology , Jg. 11 2021, 635096DOI, Online Volltext (Open Access)
-
Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLCIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 48 2021, S. 2894 – 2903DOI (Open Access)
-
Interactions Between Dose and Volume in Chemoradiotherapy of Esophageal CancerIn: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 34, S. 3880 – 3881DOI (Open Access)
-
Lokale Strahlentherapie der Prostata mit Samenblasenbasis allein oder mit elektiver Bestrahlung pelviner Lymphknotenstationen beim Hochrisiko-Prostatakarzinom? : Ergebnisse der randomisierten POP-RT-StudieIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. 10, S. 939 – 942DOI (Open Access)
-
Lung Cancer Surgery after Neoadjuvant ImmunotherapyIn: Cancers , Jg. 13 2021, Nr. 16, 4033DOI, Online Volltext (Open Access)
-
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomographyIn: Journal of Neuro-Oncology , Jg. 152 2021, S. 325 – 332
-
N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standardIn: EJNMMI Research , Jg. 11 2021, Nr. 1, 68DOI, Online Volltext (Open Access)
-
Patterns of cervical lymph node metastasis in supraglottic laryngeal cancer and therapeutic implications of surgical staging of the neckIn: European Archives of Oto-Rhino-Laryngology and Head & Neck , Jg. 278 2021, Nr. 12, S. 5021 – 5027DOI (Open Access)
-
Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definitionIn: Radiation Oncology , Jg. 16 2021, Nr. 1, 176DOI, Online Volltext (Open Access)
-
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocolIn: BMC Cancer , Jg. 21 2021, 512DOI (Open Access)
-
Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial TumorsIn: Pathology & Oncology Research , Jg. 27 2021, S. 629993DOI, Online Volltext (Open Access)
-
Preoperative and early postoperative seizures in patients with glioblastoma : two sides of the same coin?In: Neuro-Oncology Advances , Jg. 3 2021, Nr. 1, vdaa158DOI, Online Volltext (Open Access)
-
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM) , Jg. 62 2021, Nr. 12, S. 1684 – 1691DOI, Online Volltext (Open Access)
-
Radiomic models for validation in patients with locally advanced HNSCC treated with primary RTCx
ESTRO 2020 - Online Congress, 28 November to 1 December 2020,In: Radiotherapy and Oncology (The Green Journal) , Jg. 152 2021, S. 832 – S833 -
Scleral necrosis after brachytherapy for uveal melanoma : Analysis of risk factorsIn: Clinical & Experimental Ophthalmology , Jg. 49 2021, Nr. 4, S. 357 – 367DOI (Open Access)
-
Stage-dependent Outcome after definitive Chemoradiotherapy for Patients with Squamous Cell Carcinoma of the Anal Canal : A DKTK-ROG Cohort StudyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 35
-
Strong shift to atr-dependent regulation of the g₂-checkpoint after exposure to high-let radiationIn: Life , Jg. 11 2021, Nr. 6, 560DOI, Online Volltext (Open Access)
-
18 F-FDG PET/CT for Target Volume Contouring in Lung Cancer RadiotherapyIn: Journal of Nuclear Medicine (JNM) , Jg. 61 2020, Nr. Supplement 2, S. 178S – 179SDOI (Open Access)
-
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationIn: Lung Cancer , Jg. 139 2020, S. 165 – 168
-
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma : Dosimetric consequences on non-coplanar IMRT as initial results from a phase i trialIn: Radiation Oncology , Jg. 15 2020, Nr. 1, S. 83DOI, Online Volltext (Open Access)
-
Comparison of GeneChip, nCounter, and Real-Time PCR–Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell CarcinomaIn: The Journal of Molecular Diagnostics , Jg. 22 2020, Nr. 6, S. 801 – 810DOI (Open Access)
-
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improveIn: European Journal of Cancer (EJC) , Jg. 138 2020, S. 156 – 168
-
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancerIn: Lung Cancer , Jg. 149 2020, S. 10 – 16
-
Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue ToxicityIn: Frontiers in Oncology , Jg. 10 2020, S. 554883DOI, Online Volltext (Open Access)
-
Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencingIn: Cancers , Jg. 12 2020, Nr. 4, 986DOI, Online Volltext (Open Access)
-
Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression contextIn: European Journal of Cancer (EJC) , Jg. 140 2020, S. 76 – 85
-
Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based TreatmentIn: Applied Clinical Informatics , Jg. 11 2020, Nr. 2, S. 200 – 209DOI (Open Access)
-
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and SwitzerlandIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 12, S. 1068 – 1079DOI (Open Access)
-
Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic : An ESTRO-ASTRO Consensus StatementIn: International Journal of Radiation Oncology, Biology, Physics , Jg. 107 2020, Nr. 4, S. 631 – 640DOI (Open Access)
-
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic : An ESTRO-ASTRO consensus statementIn: Radiotherapy and Oncology (The Green Journal) 2020DOI (Open Access)
-
Prediction of preoperative survival in patients with glioblastoma by routine inflammatory laboratory parametersIn: Anticancer Research , Jg. 40 2020, Nr. 2, S. 1161 – 1166DOI (Open Access)
-
RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma : A randomized multicenter phase II trialIn: Clinical and Translational Radiation Oncology , Jg. 23 2020, S. 43 – 49DOI (Open Access)
-
Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image-guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloonIn: Journal of Applied Clinical Medical Physics , Jg. 22 2020, Nr. 1, S. 226 – 241DOI, Online Volltext (Open Access)
-
Superior vena cava syndrome induced collateral circulation on ⁹⁹mTc-Macroaggregated albumin lung perfusion scintigraphyIn: Clinical Nuclear Medicine , Jg. 45 2020, Nr. 10, S. E435 – E438
-
The SHORT Score for Preoperative Assessment of the Risk for Short-Term Survival in GlioblastomaIn: World Neurosurgery , Jg. 138 2020, S. e370 – e380
-
To resect or not to resect? : Risks and benefits of surgery in older patients with glioblastomaIn: Journal of Geriatric Oncology , Jg. 11 2020, Nr. 4, S. 688 – 693
-
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastomaIn: Journal of Cancer Research and Clinical Oncology , Jg. 146 2020, Nr. 3, S. 787 – 792
-
A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infectionIn: Clinical Cancer Research , Jg. 25 2019, Nr. 5, S. 1505 – 1516DOI (Open Access)
-
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular diseaseIn: International Journal of Cardiology , Jg. 280 2019, S. 163 – 175
-
Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic ImportanceIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 195 2019, Nr. Suppl. 1, S. S66 – S67
-
Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 195 2019, Nr. Suppl. 1, S. 109
-
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed GliomaIn: Clinical Nuclear Medicine , Jg. 44 2019, Nr. 6, S. e375 – e381
-
DNA-dependent protein kinase : effect on DSB repair, G2/M checkpoint and mode of cell death in NSCLC cell linesIn: International Journal of Radiation Biology (RAB) , Jg. 95 2019, Nr. 9, S. 1205 – 1219
-
Deep-learning based estimation of locoregional control for patients with locally advanced HNSCCIn: Radiotherapy and Oncology (The Green Journal) , Jg. 133 2019, Nr. Suppl. 1, S. S254 – S255DOI (Open Access)
-
Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016In: Clinical Nuclear Medicine , Jg. 44 2019, Nr. 3, S. 214 – 220
-
Impact of RAS mutation subtype on clinical outcome : A cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancerIn: Oncogene , Jg. 38 2019, Nr. 16, S. 2953 – 2966
-
Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation : a multicentre retrospective study of the German Cancer Consortium Radiation Oncology GroupIn: European Journal of Cancer (EJC) , Jg. 116 2019, S. 67 – 76
-
Kuratives Potenzial nichtoperativer Therapiekonzepte beim Adenokarzinom des ösophagogastralen ÜbergangsIn: Der Onkologe , Jg. 25 2019, Nr. 12, S. 1095 – 1102
-
Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine CarcinomaIn: The Annals of Thoracic Surgery , Jg. 107 2019, Nr. 6, S. 1632 – 1638DOI (Open Access)
-
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancerIn: Annals of Oncology , Jg. 30 2019, Nr. 4, S. 655 – 657DOI (Open Access)
-
Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivitiesIn: Scientific Reports , Jg. 9 2019, S. 1282DOI (Open Access)
-
OC-0390 TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTxIn: Radiotherapy and Oncology (The Green Journal) , Jg. 133 2019, Nr. Suppl. 1, S. 196DOI (Open Access)
-
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 46 2019, Nr. 7, S. 1439 – 1447
-
Regorafenib in patients with recurrent high-grade astrocytomaIn: Journal of Cancer Research and Clinical Oncology , Jg. 145 2019, Nr. 4, S. 1037 – 1042
-
Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV⁶⁰⁰E inhibition in melanomaIn: European Journal of Cancer (EJC) , Jg. 109 2019, S. 137 – 153
-
Simultaneous primary cancer occurrence of melanoma and pulmonary adenocarcinoma in leptomeningeal metastases: a case reportIn: BMC Cancer , Jg. 19 2019, Nr. 1, S. 995DOI, Online Volltext (Open Access)
-
Targeting ARID1A-mutant colorectal cancer : depletion of ARID1B increases radiosensitivity and modulates DNA damage responseIn: Scientific Reports , Jg. 9 2019, Nr. 1, S. 18207DOI (Open Access)
-
Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to RadiotherapyIn: Molecular Cancer Therapeutics , Jg. 18 2019, Nr. 3, S. 656 – 666DOI (Open Access)
-
Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium IIIIn: Der Onkologe , Jg. 24 2018, Nr. 12, S. 974 – 982
-
Anaplastic thyroid carcinoma : review of treatment protocolsIn: Endocrine-Related Cancer , Jg. 25 2018, Nr. 3, S. R153 – R161DOI (Open Access)
-
Combined effects of metformin and cisplatin on radiation sensitivity in non-small cell lung cancer cellsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. 100DOI (Open Access)
-
Combining different genomic signatures to improve the prognostic power for LRC after PORT-C in HNSCCIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. Suppl. 1, S. S140 – S141DOI (Open Access)
-
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCCIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. 1, S. 27 – 35DOI (Open Access)
-
Deformed planning CTs offer a better image quality presentation than CBCT data and can be used as additional scenarios in IMPT dose optimizationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. S31 – S31
-
Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapyIn: Clinical Cancer Research , Jg. 24 2018, Nr. 6, S. 1364 – 1374DOI (Open Access)
-
Effects of DNA-dependent protein kinase inhibition in NSCLC cells : DSB repair, G2/M checkpoint and mode of cell deathIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. S96 – S97DOI (Open Access)
-
Final Re-irradiation of Patients with NSCLC after primary high-dose Local TherapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. S59DOI (Open Access)
-
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy : A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)In: International Journal of Cancer , Jg. 142 2018, Nr. 9, S. 1911 – 1925DOI (Open Access)
-
Immune contexture in SCCHN and outcome after chemoradiotherapy in an uni- and multicentric cohortIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. Suppl.1, S. 172 – S173DOI (Open Access)
-
Immunonkologie von Kopf-Hals-TumorenIn: Best Practice Onkologie , Jg. 13 2018, Nr. 6, S. 336 – 349
-
Increased sensitivity of colon carcinoma cells with ARID1A mutation to radiotherapy by depletion of ARID1BIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. S173 – S174DOI (Open Access)
-
Independent validation of a new Reirradiation Risk-Score (RRRS) for Relapsed-Glioma Patients : A multicentric DKTK/ROG-StudyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. 9DOI (Open Access)
-
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival : A multicenter DKTK/ROG analysisIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. 1, S. 121 – 127
-
Inhibition of epigenetic modifiers in non-small lung cancer cell lines with loss of function mutations in SWI/SNF chromatin remodeling genes : a tool for selective radiosensitization of BRG1 mutant NSCLC cell linesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. 169 – S170DOI (Open Access)
-
Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive EffectsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl. 1, S. 110DOI (Open Access)
-
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission : retrospective follow-up of an open-label, randomised phase 3 trialIn: The Lancet Haematology , Jg. 5 2018, Nr. 4, S. e161 – e169
-
MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyIn: Clinical Lung Cancer , Jg. 19 2018, Nr. 4, S. e441 – e463
-
OC-0508: Identification of tumour sub-volumes for improved radiomic risk modelling in locally advanced HNSCCIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. Suppl. 1, S. S263 – S264DOI (Open Access)
-
OC-0588: Validation of the reRT risk score (RRRS) in glioma patients : A multicenter DKTK/ROG analysisIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. Suppl. 1, S. S307 – S308DOI (Open Access)
-
Oligometastatische Erkrankung des nichtkleinzelligen LungenkarzinomsIn: Der Onkologe , Jg. 24 2018, Nr. 12, S. 992 – 1002
-
Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 StudyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. S41 – S42DOI (Open Access)
-
Precision of Radiotherapy of Prostate with Rectum Balloon guided with 6 Degrees of Freedom (6-dof) by means of Cone Beam CT online : Evaluation of Dorsal Target Margin Abnormalities by using elastic Deformation as the Basis for an adaptive RadiotherapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl.1, S. 90 – S90DOI (Open Access)
-
Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trialIn: Radiotherapy and Oncology (The Green Journal) , Jg. 127 2018, Nr. Suppl.1, S. S253 – S254DOI (Open Access)
-
PriCoTTF : A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastomaIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl. 1, S. 73DOI (Open Access)
-
Re-irradiation of recurrent gliomas : pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)In: Cancer Medicine , Jg. 7 2018, Nr. 5, S. 1742 – 1749DOI (Open Access)
-
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapyIn: Radiotherapy and Oncology (The Green Journal) , Jg. 126 2018, Nr. 1, S. 125 – 131
-
Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. Suppl. 1, S. S23 – S24DOI (Open Access)
-
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modellingIn: Scientific Reports , Jg. 7 2017, Nr. 1, S. 13206DOI (Open Access)
-
Adjuvante Radiotherapie der neovaskulären altersabhängigen Makuladegeneration unter Anti-VEGFIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft , Jg. 114 2017, Nr. 4, S. 370 – 374
-
Defining the role of the histone acetyltransferase TIP60 in DNA damage response of glioma cell linesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl.1, S. 9
-
Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidenceIn: OncoTarget , Jg. 8 2017, Nr. 25, S. 41670 – 41678DOI (Open Access)
-
Dose-Intensified Lung Cancer Radiation Therapy by helical Tomotherapy : Evaluation of the Stability of Dose Distribution accumulated in all Breathing Phases during the TherapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl.1, S. 77
-
Epigenetic silencing and activation of transcription : influence on the radiation sensitivity of glioma cell linesIn: International Journal of Radiation Biology (RAB) , Jg. 93 2017, Nr. 5, S. 494 – 506
-
Factors for the long-term Survival of Patients with NSCLC in the Stage of oligometastatic Disease after definitive Local TherapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl. 1, S. 58
-
Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trialIn: Annals of Oncology , Jg. 28 2017, Nr. 5, S. 1084 – 1089DOI (Open Access)
-
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung CancerIn: Journal of Thoracic Oncology , Jg. 12 2017, Nr. 1, S. 54 – 64DOI (Open Access)
-
Importance of neoadjuvant Radiotherapy in the trimodal Approach in the Treatment of locally advanced, potentially resectable NSCLC - a Meta-AnalysisIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl. 1, S. S62 – S63
-
Intermodaler Vergleich von EBUS-TBNA, 18F-FDG PET/CT im Rahmen der Bestrahlungsplanung beim Lokal-fortgeschrittenen Nichtkleinzelligen Lungenkarzinom (Stadium II-IIIB)
23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2017 ; 14. - 18. Juni 2017, Berlin, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl. 1: Abstracts DEGRO 2017, S. S20 -
Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungsIn: The FASEB Journal , Jg. 31 2017, Nr. 7, S. 2869 – 2880DOI (Open Access)
-
Mesenchymal stem cell therapy protects lungs from radiation-induced endothelial cell loss by restoring superoxide dismutase 1 expressionIn: Antioxidants and Redox Signaling , Jg. 26 2017, Nr. 11, S. 563 – 582DOI (Open Access)
-
Metformin potentiates radiosensitizing effect of cisplatin in NSCLC cellsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl.1, S. 27
-
NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinomaIn: OncoTarget , Jg. 8 2017, Nr. 26, S. 42613 – 42620DOI (Open Access)
-
PET-CT for Response Assessment During Induction Therapy of N2 NSCLCIn: Journal of Thoracic Oncology , Jg. 12 2017, Nr. 1 Suppl., S. 72 – 73
-
Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET) : Long-term results of a controlled randomised trialIn: European Journal of Cancer (EJC) , Jg. 81 2017, S. 183 – 190
-
Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy ArmIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. 1, S. 20
-
Pulmonary metastasectomy for sarcoma-Essen experienceIn: Journal of Thoracic Disease , Jg. 9 2017, S. S1278 – S1281DOI (Open Access)
-
Radiotherapy Techniques in Lung CancerIn: Journal of Thoracic Oncology , Jg. 12 2017, Nr. Suppl. 1, S. 155 – 156
-
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapyIn: Clinical and Translational Radiation Oncology , Jg. 5 2017, S. 28 – 36DOI (Open Access)
-
The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy : a multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)In: International Journal of Cancer , Jg. 141 2017, Nr. 3, S. 594 – 603
-
CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy : A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)In: International Journal of Cancer , Jg. 138 2016, Nr. 1, S. 171 – 181DOI (Open Access)
-
Die neue S3-Leitlinie zum Ösophaguskarzinom : Wichtige chirurgische AspekteIn: Der Chirurg , Jg. 87 2016, Nr. 10, S. 865 – 872
-
Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung FibrosisIn: Cancer Research , Jg. 76 2016, Nr. 10, S. 3045 – 3056DOI (Open Access)
-
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy : A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)In: Radiotherapy and Oncology (The Green Journal) , Jg. 121 2016, Nr. 3, S. 364 – 373
-
Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy : A Multicenter Study of the DKTK-ROGIn: Clinical Cancer Research , Jg. 22 2016, Nr. 11, S. 2639 – 2649DOI (Open Access)
-
Small cell neuroendocrine carcinoma of the right eye : A case reportIn: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 189 – 189
-
Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung CancerIn: Journal of Clinical Oncology (JCO) , Jg. 34 2016, Nr. 21, S. 2526 – 2533
-
Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling HypoxiaIn: Antioxidants and Redox Signaling , Jg. 25 2016, Nr. 2, S. 89 – 107
-
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiationIn: European Journal of Cancer (EJC) , Jg. 57 2016, S. 78 – 86
-
Therapy with multipotent mesenchymal stromal cells protects lungs from radiation-induced injury and reduces the risk of lung metastasisIn: Antioxidants and Redox Signaling , Jg. 24 2016, Nr. 2, S. 53 – 69
-
Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyIn: Journal of Thoracic Disease , Jg. 7 2015, Nr. 3, S. 264 – 272
-
Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. 113 (2014) 317–323]In: Radiotherapy and Oncology (The Green Journal) , Jg. 114 2015, Nr. 3, S. 419
-
Dependence of radiation-induced H2AX phosphorylation on histone methylation : evidence from the chromatin immunoprecipitation assayIn: International Journal of Radiation Biology (RAB) , Jg. 91 2015, Nr. 4, S. 346 – 353
-
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagusIn: Gastric Cancer , Jg. 18 2015, Nr. 3, S. 550 – 563DOI (Open Access)
-
Multimodal treatment of non-small-cell lung cancerIn: Lancet , Jg. 386 2015, Nr. 9998, S. 1018 – 1020
-
Mutational patterns of HPV plus and HPV- squamous cell carcinomas of the head and neck (SCCHN) and their interference with outcome after adjuvant chemoradiation : A multicenter biomarker study of the German Cancer Consortium Radiation Oncology GroupIn: Journal of Clinical Oncology (JCO) , Jg. 33 2015, Nr. 15 Suppl., S. 6006
-
New model for long-term investigations of cutaneous microcirculatory and inflammatory changes following irradiationIn: Journal of Radiation Research , Jg. 56 2015, Nr. 3, S. 456 – 461DOI (Open Access)
-
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)In: Journal of Clinical Oncology (JCO) , Jg. 33 2015, Nr. 35, S. 4194 – 4201
-
Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factorsIn: BMC Cancer , Jg. 15 2015, Nr. 1, S. 363DOI (Open Access)
-
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0 – September 2015, AWMF-Registernummer: 021/023OL)In: Zeitschrift für Gastroenterologie , Jg. 53 2015, Nr. 11, S. 1288 – 1347
-
Creating a data exchange strategy for radiotherapy research : towards federated databases and anonymised public datasetsIn: Radiotherapy and Oncology (The Green Journal) , Jg. 113 2014, Nr. 3, S. 303 – 309DOI (Open Access)
-
Ductal pancreatic adenocarcinomaIn: Deutsches Ärzteblatt international , Jg. 111 2014, Nr. 22, S. 396 – 402DOI (Open Access)
-
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma : Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)In: Radiotherapy and Oncology (The Green Journal) , Jg. 113 2014, Nr. 3, S. 317 – 323DOI (Open Access)
-
Hyperfractionated and accelerated radiotherapy in non-small cell lung cancerIn: Journal of Thoracic Disease , Jg. 6 2014, Nr. 4, S. 328 – 335
-
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagusIn: Diseases of the Esophagus , Jg. 27 2014, Nr. 7, S. 678 – 684
-
Mesenchymal stem cell therapy antagonizes radiation-induced endothelial cell damage and metastasisIn: European Journal of Cancer (EJC) , Jg. 50 2014, Nr. Suppl. 5, S. 221
-
Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)In: Journal of Clinical Oncology (JCO) , Jg. 32 2014, Nr. 15 Suppl., S. 7510
-
Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cellsIn: Radiation Oncology , Jg. 9 2014, Nr. 1, 98DOI (Open Access)
-
10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)In: Lung Cancer , Jg. 82 2013, Nr. 1, S. 83 – 89
-
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionationIn: European Journal of Cancer (EJC) , Jg. 49 2013, Nr. 9, S. 2107 – 2115
-
Accuracy of the Position of the Tumor, Lymph Nodes, Esophagus and Diaphragm in image-guided Radiation therapy of Lung Cancer by Carina Match or Bone MatchIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 88
-
Basic Performance Comparison Between Two Types of Proton Beam Modulated Scanning SystemsIn: Medical Physics , Jg. 40 2013, Nr. 6Part17, S. 298
-
Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicityIn: Journal of Clinical Oncology (JCO) , Jg. 31 2013, Nr. 30, S. 3844 – 3845
-
DNA-dependent protein kinase (DNA-PK) as a potential therapeutic target in non-small lung cancer cell lines (NSCLC)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 123 – 123
-
Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neckIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. 8, S. 625 – 631
-
Follicular lymphoma : final results of the randomized evaluation of curative radiotherapy in limited stage nodal diseaseIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 36 – 36
-
Helical Tomotherapy for Whole-Brain Radiotherapy with integrated Boost in Patients with multiple Brain Metastases and Re-Irradiation of ENT Tumors : Optimization of Compromise between Dose Conformity and Exposure TimeIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 59 – 60
-
Helical tomotherapy for whole-brain irradiation with integrated boost to multiple brain metastases : evaluation of dose distribution characteristics and comparison with alternative techniquesIn: International Journal of Radiation Oncology, Biology, Physics , Jg. 86 2013, Nr. 4, S. 734 – 742
-
Kombination von BRAF-Inhibitoren (BRAFi) und zerebraler Bestrahlung bei Patienten mit metastasiertem Melanom : Eine mögliche Behandlungsoption für neu aufgetretene oder pro-grediente Hirnmetastasen unter Therapie mit BRAF-InhibitorenIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) , Jg. 11 2013, Nr. 9, S. 952 – 952
-
Megavoltage computed tomography image guidance with helical tomotherapy in patients with vertebral tumors : analysis of factors influencing interobserver variabilityIn: International Journal of Radiation Oncology, Biology, Physics , Jg. 85 2013, Nr. 2, S. 561 – 569
-
Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck regionIn: Radiation Oncology , Jg. 8 2013, Nr. 1, S. 145DOI (Open Access)
-
Novel prognostic scoring system after surgery for klatskin tumorIn: The American Surgeon / Southeastern Surgical Congress (SESC) (Hrsg.) , Jg. 79 2013, Nr. 1, S. 90 – 95
-
Pudendal nerve block in HDR-brachytherapy patients : Do we really need general or regional anesthesia?In: World Journal of Urology , Jg. 31 2013, Nr. 2, S. 417 – 421
-
Radiation-induced Normal Tissue Damage require the Settlement of circulating Tumor cellsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 125
-
Re-irradiation of recurrent head and neck carcinomas : Comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapyIn: Radiation Oncology , Jg. 8 2013, Nr. 1, S. 93DOI (Open Access)
-
S3-Leitlinie zum exokrinen PankreaskarzinomIn: Zeitschrift für Gastroenterologie , Jg. 51 2013, Nr. 12, S. 1395 – 1440
-
Thorax irradiation triggers local and systemic immune changesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 125 – 126
-
Addressing barriers to patient accrual in clinical trials : lessons from the eortic prostate cancer trial 22043-30041In: The Journal of Urology , Jg. 187 S 2012, Nr. 4 Suppl., S. E389 – E389
-
Dosimetrische Bewertung residualer zufälliger Setup-Fehler nach bildgeführter intensitätsmodulierter Strahlentherapie von Schädelbasistumoren mittels helikaler TomotherapieIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 163
-
Effektivität und Toxizität von bildgeführter hochkonformaler Bestrahlung multipler zerebraler Metastasen mit/ohne Ganzhirnbestrahlung (WBRT) mittels helikaler TomotherapieIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 41 – 42
-
Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/ToxizitätenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. Suppl. 1, S. 34
-
Evaluation robuster intensitätsmodulierter Scanning-Protonen-Pläne für lokal fortgeschrittene Lungenkarzinome im Vergleich zur intensitätsmodulierten Photonentherapie bei Bestrahlung in InspirationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 10 – 11
-
Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. Suppl. 1, S. 96 – 96
-
Increased effect of Aurora-B kinase inhibition on endoreplicated non-small lung cancer cell linesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 115
-
Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell linesIn: International Journal of Radiation Oncology, Biology, Physics , Jg. 84 2012, Nr. 2, S. 492 – 499
-
Inter- und Intra-Fraktionen-Variabilität von Deep-Inspiration Breath-Hold Manövern bei der hochdosierten Strahlentherapie von LungenkarzinomenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 45
-
Langzeitergebnisse nach Re-Radiotherapie bei Patienten mit einem Tumorrezidiv bzw. Zweitkarzinom im Kopf-Hals-BereichIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. Suppl. 1, S. 52
-
Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plansIn: Radiotherapy and Oncology (The Green Journal) , Jg. 104 2012, Nr. 1, S. 45 – 51
-
Prediction of prognosis after trimodal therapy in patients with locally advanced squamous cell carcinoma of the oesophagusIn: European Journal of Cancer (EJC) , Jg. 48 2012, Nr. 16, S. 2977 – 2982
-
Quo vadis, Protonen? : Moderne StrahlentherapieIn: Unikate: Berichte aus Forschung und Lehre 2012, Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 136 – 144DOI, Online Volltext (Open Access)
-
Radiotherapy versus surgery within multimodality protocols for esophageal cancer – A meta-analysis of the randomized trialsIn: Cancer Treatment Reviews , Jg. 38 2012, Nr. 6, S. 599 – 604
-
Reduced contribution of thermally-labile sugar lesions to DNA double-strand break formation after exposure to neutronsIn: Radiation Research , Jg. 178 2012, Nr. 6, S. 581 – 590
-
Residual damage measured by γH2AX accumulation during fractionated irradiation is correlated with radioresponsiveness of tumor cellsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 140 – 141
-
Simultane Radiochemotherapie des Analkanalkarzinoms – eine retrospektive StudieIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 70
-
The effects of motion on the dose distribution of proton radiotherapy for prostate cancerIn: Journal of Applied Clinical Medical Physics , Jg. 13 2012, Nr. 3, S. 3 – 11DOI (Open Access)
-
Total body irradiation (TBI) in the conditioning regimens prior to hematopoietic stem cell transplantation (HSCT) : Long-term follow-up of 98 pediatric patientsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. Suppl. 1, S. 108
-
Überprüfung von Methoden zur Positionierung von HNO-Tumor-Patienten während der IGRT-Behandlung unter Verwendung von kV-BildgebungsvorrichtungenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 158
-
10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)In: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 6, Suppl. 2, S. 494
-
15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIMIn: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 6, Suppl. 2 , S.S 492 - S493
-
Accuracy of Image Guidance by mega-voltage CT (MVCT) with helical Tomotherapy of Spinal tumorsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 18 – 18
-
Combined modality treatment, especially concomitant chemoradiation : Which chemotherapy? Which Radiotherapy fractionation scheme?Toxicities?In: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 6, Suppl. 2, S. S214 – S215
-
Definitive Chemoradiotherapy in locally advanced cervical Carcinoma of the EsophagusIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 117
-
Effect of Aurora-B kinase inhibition on radiation induced cell-cycle checkpoint activation and cell death in non-small lung cancer cell linesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 123
-
Follicular Lymphoma : Curability by Radiotherapy in limited stage nodal disease? Updated results of a randomized trialIn: Annals of Oncology , Jg. 22 2011, Nr. Suppl. 4, S. 90 – 90
-
Follicular lymphoma : Updated results of the randomized evaluation of curative radiotherapy in limited stage nodal disease and analysis of relapseIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 29 – 30
-
Helical Tomotherapy for Whole Brain Radiotherapy with integrated Boost for Patients with multiple Brain Metastases : Evaluation of Dosis Distributions and dosimetric AccuracyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 34 – 35
-
Hypofractionated image-guided radiotherapy (HF-IGRT) cerebral metastases by means of helical TomotherapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 19 – 19
-
Intraoperative Irradiation of the Tumor bed as a Boost in the Burst-sustaining Primary treatment of Breast cancer - Initial results and issues that arisesIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 99 – 100
-
Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. 7042
-
Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VEIn: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 6, Suppl. 2, S. 495
-
Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)In: Journal of Clinical Oncology (JCO) , Jg. 29 2011, Nr. 15_suppl, S. 7047
-
Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 68 – 69
-
Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen LungenkarzinomsIn: Der Onkologe , Jg. 17 2011, Nr. 8, S. 691 – 701
-
New insights into the molecular pathology of radiation-induced pneumopathyIn: Radiotherapy and Oncology (The Green Journal) , Jg. 101 2011, Nr. 1, S. 86 – 92
-
Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged versionIn: Pneumologie , Jg. 65 2011, Nr. 8, S. e51 – e75
-
S3-Leitlinie „Magenkarzinom” : Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen ÜbergangsIn: Zeitschrift für Gastroenterologie , Jg. 49 2011, Nr. 4, S. 461 – 531
-
Effectiveness of adjuvant chemotherapy for resected NSCLCIn: Nature Reviews Clinical Oncology , Jg. 7 2010, Nr. 11, S. 613 – 614
-
Follicular lymphoma : Updated results of the randomized evaluation of curative radiotherapy in limited stage nodal disease
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 77 – 78 -
Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trialIn: International Journal of Radiation Oncology, Biology, Physics , Jg. 76 2010, Nr. 3, S. 809 – 815
-
Multimodale Therapie beim Plattenepithelkarzinom des ÖsophagusIn: Der Onkologe , Jg. 16 2010, Nr. 5, S. 496 – 503
-
PET/CT-basierte Response-Evaluation nach Induktions-Chemotherapie in einem prospektiven Protokoll für die dosisgesteigerte Strahlentherapie bei uT3/T4 ÖsophaguskarzinomenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 27 – 28
-
Phase I/II Trial of Preoperative Oxaliplatin, Docetaxel, and Capecitabine with Concurrent Radiation Therapy In Localized Carcinoma of the Esophagus or Gastroesophageal JunctionIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. 12, S. 708 – 710
-
Predictive factors in locally advances squamous cell carcinoma (SCC) of the oesophagus treated with preoperative radiochemotherapy (RCT) and surgery
35th ESMO Congress, Milan, Italy 8–12 October 2010,In: Annals of Oncology , Jg. 21 2010, Nr. Suppl. 8, S. 252 – 252 -
Prävention, Diagnostik, Therapie und Nachsorge des LungenkarzinomsIn: Pneumologie , Jg. 64 2010, Nr. Suppl. 2, S. e1 – e164
-
Pudendusblockade oder kombinierte Spinal-Epidural-Anästhesie (CSE) bei der High-Dose-Rate-Brachytherapie des Prostatakarzinoms?In: Aktuelle Urologie , Jg. 41 2010, Nr. 1, S. 43 – 51
-
Risikoadaptierte Strahlentherapie bei brusterhaltender Therapie des frühen Mammakarzinoms : Aktuelle EntwicklungenIn: Der Gynäkologe , Jg. 43 2010, Nr. 10, S. 848 – 852
-
TH‐C‐BRB‐09: Design and Initial Performance of a Large Cross‐Section Multi‐Element Ionization Chamber System for Water Equivalent Range Measurements of Pristine Proton FieldsIn: Medical Physics , Jg. 37 2010, Nr. 6, S. 3454 – 3455
-
Use of γH2AX and other biomarkers of double-strand breaks during radiotherapyIn: Seminars in Radiation Oncology , Jg. 20 2010, Nr. 4, S. 223 – 231
-
Work in Progress : Preliminary testing of a multi-element detector measurement system for water equivalent range measurements of pristine proton fields
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 100 – 100 -
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphomaIn: Journal of Cancer Research and Clinical Oncology , Jg. 135 2009, Nr. 3, S. 459 – 466
-
Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancerIn: Oncology , Jg. 73 2008, Nr. 5-6, S. 316 – 323
-
Gründung einer Arbeitsgruppe „Lymphknotenmetastasierung“ am Westdeutschen Tumorzentrum (WTZE), Universitätsklinikum EssenIn: Der Urologe , Jg. 46 2007, Nr. 9, S. 1257 – 1260
-
Identifikation der molekularen Grundlagen der Metastasierung zur Entwicklung neuer Therapiestrategien des metastasierten ProstatakarzinomsIn: Der Urologe , Jg. 46 2007, Nr. 9, S. 1261 – 1262
-
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumourIn: European Respiratory Journal , Jg. 29 2007, Nr. 1, S. 117 – 127DOI (Open Access)
-
Morphological and functional evaluation of angiogenesis of a xenografted human sarcoma in nude miceIn: Laboratory Animals , Jg. 41 2007, Nr. 2, S. 239 – 246DOI (Open Access)
-
Proapoptotische Antikörper als neue TumortherapeutikaIn: Der Urologe , Jg. 46 2007, Nr. 9, S. 1262 – 1265
-
Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapyIn: Clinical Cancer Research , Jg. 12 2006, Nr. 1, S. 97 – 106
-
Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagusIn: Journal of Clinical Oncology , Jg. 23 2005, Nr. 10, S. 2310 – 2317
-
Prinzipielle Probleme der LymphknotenchirurgieIn: Der Urologe: Ausgabe A , Jg. 44 2005, Nr. 6, S. 605 – 607
-
Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth : potentiation by irradiationIn: International Journal of Cancer , Jg. 106 2003, Nr. 5, S. 723 – 728
-
Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphomaIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 179 2003, Nr. 9, S. 626 – 632
-
Krebs und Schwangerschaft – Fakten und FiktionenIn: Der Onkologe , Jg. 18 2012, Nr. 4, S. 298 – 300
-
Oncological outcome of re-irradiation for recurrent glioblastoma : Results of a prospective multicenter trial (GLIAA, NCT01252459)In: Radiotherapy and Oncology (The Green Journal) , Jg. 206 2025, Nr. Supplement 1, S. S698 – S700
-
Deciphering Destiny : Is Curation of NSCLC Limited to Stage IA?In: Journal of Thoracic Oncology , Jg. 19 2024, Nr. Suppl. 10, S. S552
-
Decoding glioblastoma survival : Unraveling the prognostic potential of olfactory function in a prospective observational study
29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,In: Neuro-Oncology , Jg. 26 2024, Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii95 – viii95 -
Impact of Preoperative Pulmonary Function on Survival Following Lobectomy for Stage I and II Lung CancerIn: Journal of Thoracic Oncology , Jg. 19 2024, Nr. Suppl. 10, S. S531
-
Lung Cancer in Young Adults is Associated with Advanced Disease at Diagnosis and Increased Frequency of Targetable MutationsIn: Journal of Thoracic Oncology , Jg. 19 2024, Nr. Suppl. 10, S. S84 – S85
-
The Influence of Smoking on Morbidity and Early Mortality after Anatomical Lung Resections for Stage I-IIIA NSCLCIn: Journal of Thoracic Oncology , Jg. 19 2024, Nr. Suppl. 10, S. S143 – S144
-
68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 50 2023, Nr. 1 supplement, S. S265 -
68Ga-SSO-120 versus 18F-FDG PET in the Initial Staging of Small-Cell Lung Cancer PatientsIn: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 50 2023, Nr. Suppl. 1, Annual Congress of the European Association of Nuclear Medicine September 9–13, 2023 Vienna, Austria, S. 488 – S489
-
68Ga-Satoreotide PET for Staging of Small-Cell Lung Cancer PatientsIn: Journal of Nuclear Medicine (JNM) , Jg. 64 2023, Nr. Suppl. 1, P165
-
A multicentric retrospective analysis of the potential synergy between radiotherapy and CAR T-cells
ESTRO 2023 ; 13 - 16 May 2023, Vienna, Austria,In: Radiotherapy and Oncology (The Green Journal) , Jg. 182 2023, Nr. Supplement 1, S. S800 – S801 -
Adaptationszeit bestimmt den PTV-Margin : Analyse von 120 Fraktionen mit online adaptiver Strahlentherapie (ART) bei 6 Patienten mit BlasenkarzinomIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. 1 – 192DOI (Open Access)
-
Cell cycle specific analysis of cisplatin-radiation interactions : Focus on DNA double strand break induction and processingIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023DOI (Open Access)
-
Decoding glioblastoma survival : unraveling the prognostic potential of olfactory function in a prospective observational study
28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,In: Neuro-Oncology , Jg. 25 2023, Nr. Suppl. 5, S. v92 – v92 -
Defects in DNA Damage Response Reinforce Proton Beam Specific Radiosensitivity of Cancer Cells
29. Kongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 22. bis 24. Juni 2023, Kassel, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S36 – S37DOI (Open Access) -
Effect of combined Cisplatin treatment and Mre11 inhibition on radiation induced DSB Repair in NSCLC cell lines and human fibroblast cellsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S138DOI (Open Access)
-
Enhanced engagement of homologous recombination repair at low doses of radiation provides rationale for dose fractionation in the clinicIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S135DOI (Open Access)
-
Gibt es unterschiedliche Verteilungsmuster zwischen strahlen- oder immuninduzierten Pneumonitiden in Abhängigkeit von der Dosisverteilung?In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S167 – S168DOI (Open Access)
-
Immunogenicity of an additional dose of covid-19 vaccine in fully vaccinated patients with glioma to evaluate new national vaccination guidelines : a prospective cohort studyIn: Neuro-Oncology , Jg. 25 2023, Nr. Suppl. 5, S. v63 – v64
-
Inter- und intrafraktionale Variabilität der Position der ventralen Rektumwand bei Verwendung eines Rektumballons während der online adaptiven Strahlentherapie (oART) von ProstatakarzinomenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S143DOI (Open Access)
-
Investigating safety and efficacy of ttfields prior and concomitant to radiotherapy in newly diagnosed glioblastoma : First results of the pricottf phase I/II trial
28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,In: Neuro-Oncology , Jg. 25 2023, Nr. Suppl. 5, S. v91 – v92 -
KI-basierte Segmentierung von Strukturen des limbischen Systems zur verbesserten Schonung durch nonkoplanare Einstrahlrichtungen in Relation zu koplanarer Optimierung der Dosis-Verteilung bei der Strahlentherapie von GliomenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S68DOI (Open Access)
-
Kreuzvalidierte Prognoseparameter C-reaktives Protein und Blutbild-Parameter im Verlauf der kurativ intendierten Radiochemotherapie bei Patienten mit nichtkleinzelligem Lungenkarzinom (NSCLC) im Stadium IIIA-CIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S100 – S101DOI (Open Access)
-
Langzeitergebnisse nach hypofraktionierter ablativer Präzisionsbestrahlung bei Patienten mit multiplen cerebralen MetastasenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S124DOI (Open Access)
-
Langzeitüberleben und konkurrierende Risiken von Patienten einer randomisierten Studie zur defnitiven vs. neoadjuvanten Radiochemotherapie + Resektion mit einem nach der Induktion resektablen NSCLC im Stadium IIIIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S7 – S8DOI (Open Access)
-
Linsenschonende Elektronenbestrahlung bei konjunktivalen Non-Hodgkin Lymphomen : Monozentrische Langzeitdaten zur Efektivität und NebenwirkungenIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S106DOI (Open Access)
-
Long-term Survival in Patients with oligometastatic Lung Cancer (cT4 or cN2-3, cM1a-c) after thoracic Chemoradiation, Metastasis-directed and Systemic Therapy compared with the Outcome in locally advanced Lung Cancer (cT4 or cN2-3, cM0)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S101 – S102DOI (Open Access)
-
Lässt sich die klassische IGRT durch online-onboard ART bei der Behandlung von Patienten mit Prostatakarzinom weiter verbessern?In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S52 – S53DOI (Open Access)
-
Online-adaptative Strahlentherapie bei der kurativen Strahlentherapie von Lungentumoren in tiefer Inspiration, welche Bedeutung hat sie?In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S85DOI (Open Access)
-
Online-adaptive Strahlentherapie beim muskelinvasiven Blasenkarzinom mit angepassten PTVSäumen : Vorteil gegenüber der IGRT zum Zeitpunkt der Adaptation und gute akkumulierte EUD zum Zeitpunkt der ApplikationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S153DOI (Open Access)
-
Rationale for increased implementation of high LET ionizing radiation in cancer therapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S135 – S136DOI (Open Access)
-
Real-world Daten zur Erhaltungstherapie mit Durvalumab nach defnitiver Strahlenchemotherapie bei Patienten mit Nicht-Kleinzelligem Lungenkarzinom in lokal fortgeschrittenen Stadien : Daten aus der Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S103DOI (Open Access)
-
Replizierbarkeit der Samenblasen-Lage bei der adaptiven Strahlentherapie (ART) des ProstatakarzinomsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S153DOI (Open Access)
-
Safety and efcacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma : the PriCoTTF phase I/II trialIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S32DOI (Open Access)
-
Targeting Polθ robustly enhances radiosensitization by talazoparib in cancer cellsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 199 2023, Nr. Suppl. 1, S. S135DOI (Open Access)
-
Temporal muscle thickness as a prognostic marker in a real-life cohort of newly diagnosed MGMT promoter methylated glioblastoma patients : a multicentric imaging analysisIn: Neuro-Oncology , Jg. 25 2023, Nr. Suppl. 5, S. v192 – v193
-
Testing for and frequency of EGFR and ALK alterations in patients with early and locally advanced non-small cell lung cancer in Germany : Results from the prospective German Registry CRISP (AIO-TRK-0315)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,In: Oncology Research and Treatment , Jg. 46 2023, Nr. Supplement 5: DGHO Abstracts, S. 10 – 11DOI (Open Access) -
68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,In: European Journal of Nuclear Medicine and Molecular Imaging , Jg. 49 2022, Nr. Supplement 1, S. S107DOI (Open Access) -
A Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma : The PriCoTTF phase I/II trialIn: Neuro-Oncology , Jg. 24 2022, Nr. Suppl. 2, S. ii14 – ii14DOI (Open Access)
-
Auf maschinellem Lernen basierende Vorhersage der uniformen Equivalentdosis im CTV bei der in exhale gagateten VMAT oder IMRT beim lokal fortgeschrittenem NSCLC : zusätzlicher Wert von geometrischen/anatomischen gegenüber rein dosimetrischen Parametern?
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S16 – S17DOI (Open Access) -
Biomarker development from joint analyses of HNSCC xenografts and patients treated by PORT-C
ESTRO 2022: Learning from every patient, 6-10 May 2022, Copenhagen,In: Radiotherapy and Oncology (The Green Journal) 2022, Nr. Band Supplement 1: ESTRO 2022, 6-10 May 2022, Copenhagen. Onsite in Copenhagen and Online (2022), S. S214 – S215 -
Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP) : Real-world evidence of NSCLC patients treated with radiochemotherapy in Germany – AIO-TRK-0315
ESMO Congress 2022, 9 - 13 September 2022, Paris, France and virtual,In: Annals of Oncology , Jg. 33 2022, Nr. Supplement 7: Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022, S. S988DOI (Open Access) -
Combination of Trofosfamide and Etoposide in Recurrent GliomaIn: Neuro-Oncology , Jg. 24 2022, Nr. Suppl. 2, S. ii89 – ii89DOI (Open Access)
-
DSB complexity : A key to cell lethalityIn: Radiotherapy and Oncology (The Green Journal) , Jg. 170 2022, Nr. Suppl. 1, S. 754 – S754
-
Integration von p16/HPV-DNA-Status mit einem 24-miRNA- definierten molekularen Phänotyp verbessert die klinisch relevante Stratifizierung von HNSCC Patienten
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S53 – S54DOI (Open Access) -
Klinische Plattform zur Erforschung molekularer Testung, Behandlung und Krankheitsverlauf von Patienten mit Lungenkrebs (CRISP) : Real-World Evidence zu NSCLC Patienten behandelt mit Radiochemotherapie in Deutschland - AIO-TRK-0315
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment , Jg. 45 2022, Nr. Supplement 2, S. 269 – 270DOI (Open Access) -
Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLCIn: Journal of Thoracic Oncology , Jg. 17 2022, Nr. 9, S. 65
-
PORT-C improves LRC in a subset of patients with intermediate-risk HNSCC : A matched pair analysis
ESTRO 2022: Learning from every patient, 6-10 May 2022, Copenhagen,In: Radiotherapy and Oncology (The Green Journal) , Jg. Supplement 1: ESTRO 2022, 6-10 May 2022, Copenhagen. Onsite in Copenhagen and Online 2022, S. S114 – S115 -
Perspektiven für die tägliche adaptive online-onboard Strahlentherapie für Patientinnen mit Zervixkarzinom
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S25DOI (Open Access) -
Preoperative PET-SUVmax and Volume Based PET Metrics of the Tumor Fail to Predict Nodal Upstaging in Early-Stage Lung CancerIn: Journal of Thoracic Oncology , Jg. 17 2022, Nr. 9, S. 203
-
Profil der multizentrischen Kohorte der Klinischen Kommunicationsplattform des Deutschen Konsortiums für Translationale Krebsforschung (DKTK)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment , Jg. 45 2022, Nr. Supplement 2, S. 13DOI (Open Access) -
Prädiktion der Toleranzdosis des Nervus opticus mittels kreuzvalidiertem maschinellem Lernen : Quantitative Analyse von Daten nach Brachytherapie von Aderhautmelanomen
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S21DOI (Open Access) -
Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S15DOI (Open Access) -
Unabhängiger Check der Ethos®-Dosisakkumulation für das PTV bei den initialen On-Couch Adaptiven Bestrahlungen von Beckentumoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S17 – S18DOI (Open Access) -
A 24-miRNA signature predicting HPV status in head and neck cancer
ESTRO 2020 - Online Congress, 28 November to 1 December 2020,In: Radiotherapy and Oncology (The Green Journal) , Jg. 152 2021, S. 27 – S28 -
A 6-gene signature for loco-regional control prognosis in HNSCC patients treated by PORT-CIn: Radiotherapy and Oncology (The Green Journal) , Jg. 161 2021, Nr. Suppl. 1, S. 186 – S187
-
Clinical Platform for Research into molecular Testing, Treatment and Disease Progression in Patients with Lung Cancer (CRISP) : First Real-World Evidence on Stage II and III NSCLC in Germany - AIO-TRK-0315In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. S11 – S12
-
Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC Stage II and III in Germany - AIO-TRK-0315
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment , Jg. 44 2021, Nr. Supplement 2, S. 3DOI (Open Access) -
Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. S935 – S936DOI (Open Access)
-
EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLCIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 142
-
IMRT/VMAT Therapy for locally advanced Lung Cancer gated on the Expiratory Phase according to 6D-Image Guidance : Stability of the accumulated Effective Uniform Dose (gEUD) and Influencing Factors for interfractional DeviationsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 146
-
Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical IrradiationIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 183
-
Long-term Follow-Up in Patients with Stage IAE Orbital Lymphoma and Radiotherapy with Photons : Monocentric ResultsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 58 – S59
-
Organ Stress with an optimized tangential IMRT-Technique in the Irradiation of the Breast/Thoracic Wall and the regional Lymphatic Drainage Pathways in Patients with locally advanced Breast CancerIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 137 – S138
-
PRICOTTF trial : A phase I/II trial of TTfields prior and concomitant to radiotherapy in newly diagnosed glioblastomaIn: Neuro-Oncology , Jg. 23 2021, Nr. Suppl. 2, S. 50
-
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study Protocol
AACR Annual Meeting 2021, April 10-15, 2021 and May 17-21, 2021, Philadelphia, PA, USA,In: Cancer Research , Jg. 81 2021, Nr. Suppl. 13, CT257 -
Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245
2021 Genitourinary Cancers Symposium, 11 - 13 Feb 2021, online,In: Journal of Clinical Oncology (JCO) , Jg. 39 2021, Nr. 6, Supplement, S. TPS172DOI (Open Access) -
PriCoTTF Trial : A Phase I//II Trial of TTFields Prior and Concomitant to Radiotherapy in newly diagnosed Glioblastoma
2021 Society for Neuro-Oncology’s 26th Annual Scientific Meeting and Education Day,In: Neuro-Oncology , Jg. 23 2021, Nr. Supplement_6, S. vi68 – vi68DOI (Open Access) -
Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the EsophagusIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 154 – S155
-
Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 176
-
Results of an automatic Workflow for Atlas-based Contouring of thoracic Risk Structures for RadiotherapyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 224 – S225
-
Synthetic lethality concepts for colon cancer cell lines in the background of mutations in the SWI/SNF complexIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1, S. 29
-
Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment , Jg. 44 2021, Nr. Supplement 2, S. 58DOI (Open Access) -
18F-Fluorethyltyrosine positron emission tomography versus magnetic resonnace spectroscopy in preoperative detection of newly diagnosed gliomas by using machine learningIn: Neuro-Oncology , Jg. 22 2020, Nr. Supplement 2, S. ii149DOI (Open Access)
-
Atmungs-kontrollierte Radiotherapie (RT) bei der Behandlung von Patienten mit Lungentumoren : Vorteile der „Inspiratorybreath- hold“-RT gegenüber dem Gating in Exspiration abhängig von der Tumorlokalisation
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S42 – S43DOI (Open Access) -
CD4+T-Lymphocytes impact macrophage polarization in irradiated lungs and promote progression of radiation-induced lung fibrosis
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S26 – S27DOI (Open Access) -
Chaetocin induced chromatin condensation in NSCLC : effect on DNA repair signaling and survival
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement : Abstracts DEGRO 2020, S. S110DOI (Open Access) -
Cross talk between T lymphocytes and macrophages promotes progression of radiation induced lung fibrosis
Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24; Philadelphia, USA,In: Cancer Research , Jg. 80 2020, Nr. Suppl. 16, S. LB – 071DOI (Open Access) -
Deep learning enabled prediction of isocitrate dehydrogenase mutation status from digtial histapathology data in glioblastomaIn: Neuro-Oncology , Jg. 22 2020, Nr. Supplement 2, S. ii167DOI (Open Access)
-
Evaluation der Korrelation des anatomischen und funktionellen CT-Ventilations- und SPECT-Perfusions-Lungenvolumens bei Patienten mit Nicht-kleinzelligem Lungenkarzinom
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S145 – S146DOI (Open Access) -
Evaluation der dosimetrischen Auswirkungen der geometrischen Variation der Tumor Treating Field (TTF) Elektroden-Positionierung in der PriCoTTF-Phase I/II Studie
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S65DOI (Open Access) -
Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S143DOI (Open Access) -
Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher Intelligenz
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S57 – S58DOI (Open Access) -
Planungsstudie für NSCLC mit Photonen-IMRT/IGRT und zwei verschiedenen Protonen delivery-Techniken in prospektivem Exhale Gating oder Breathhold
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S87 – S88DOI (Open Access) -
PriCoTTF Trial : A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S74DOI (Open Access) -
Pricottf trial : a phase I/II trial of ttfields prior and concomitant to radiotherapy in newly diagnosed glioblastomaIn: Neuro-Oncology , Jg. 22 2020, Nr. Supplement_2, S. ii61 – ii61DOI (Open Access)
-
Quantitative Analyse der posterioren Prostatakontur über die Bestrahlungsserie bei der bildgeführten Strahlentherapie der Prostata mit Rektumballon : Eine Adaptation an systematische Abweichungen von der geplanten Kontur führt zur Verbesserung der therapeutischen Breite
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S92 – S93DOI (Open Access) -
Radiochemotherapie bei lokal fortgeschrittenen intra und extrahepatischen Gallenwegstumoren : niedriges Toxizitätsprofil bei hoch-konformalen Dosisverteilungen in Atem-getriggerter Bestrahlung
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S153DOI (Open Access) -
Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy : A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
62nd Annual Meeting of the American Society for Radiation Oncology ; October 25-28, 2020, virtual,In: International Journal of Radiation Oncology, Biology, Physics , Jg. 108 2020, Nr. 3, S. S161 -
Targeted therapy concepts for ARID1A-mutated colon cancer cell lines
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S192DOI (Open Access) -
Validating gene signatures in locally advanced HNSCC patients treated by PORT-C and in xenografts
ESTRO 2020 - Online Congress, 28 November to 1 December 2020,In: Radiotherapy and Oncology (The Green Journal) , Jg. 152 2020, Nr. Supplement 1, S. 319 – S320 -
Vergleichende Analyse verschiedener coplanarer und non-coplanarer Bestrahlungstechniken bei Patienten mit Glioblastom im Hinblick auf die dosimetrischen Optimierungs-Möglichkeiten
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S69 – S70DOI (Open Access) -
Vorhersage und Aufklärung der molekularen Mechanismen bei HPV-getriebenen und klassischen Kopf-Hals-Tumoren mittels miRNA-Signatur
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S25 – S26DOI (Open Access) -
Welche Standard-PTV-Säume werden bei gegateter Strahlentherapie in Exspiration bei lokal fortgeschrittenen Lungenkarzinomen nach online-Navigation benötigt?
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S58DOI (Open Access) -
Wissensbasierte Bestrahlungsplanung : Dosimetrische Validierung eines RapidPlan®-Modells zur automatisierten Erstellung von RapidArc® Plänen bei Patienten mit Glioblastom
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S34DOI (Open Access) -
A Methylome Classifier Identifies Patients at Risk for Locoregional Recurrence after Adjuvant Radiochemotherapy in HPV-DNA negative HNSCC : a Multicenter Trial of the German Cancer Consortium- Radiation Oncology Group (DKTK-ROG)
61st Annual Meeting of the Amercian Society for Radiation Oncology ; 15-18 September 2019, Chicago, IL, USA,In: International Journal of Radiation Oncology, Biology, Physics , Jg. 105 2019, Nr. 1, Supplement, S. S17 – S18DOI (Open Access) -
Advanced Age and High Modified Glasgow Prognostic Score Are Associated with Increased Complications After PneumonectomyIn: Journal of Thoracic Oncology , Jg. 14 2019, Nr. 10, Supplement, S. S677DOI (Open Access)
-
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
61st Annual Meeting of the American Society for Radiation Oncology ; September 15-18, 2019, Chicago, IL, USA,In: International Journal of Radiation Oncology, Biology, Physics , Jg. 105 2019, Nr. 1, Supplement, S. S146 – S147DOI (Open Access) -
Tumor Treating Fields (TTFields) combined with lomustine (CCNU) and temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) patients - a bi-centric analysisIn: Neuro-Oncology , Jg. 21 2019, Nr. Supplement_3, S. iii81DOI (Open Access)
-
ACTR-49. PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,In: Neuro-Oncology , Jg. 20 2018, Nr. suppl_6, S. vi22 – vi23DOI (Open Access) -
HOUT-30. TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,In: Neuro-Oncology , Jg. 20 2018, Nr. suppl_6, S. vi119 – vi120DOI (Open Access) -
Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 109 – 110DOI (Open Access) -
Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 1, S. 108DOI (Open Access) -
PriCoTTF : a phase I/II trial of Tumor Treating Fields prior and concomitant to radiotherapy in newly diagnosed glioblastomaIn: Neuro-Oncology , Jg. 20 2018, Nr. suppl_3, S. iii243 – iii243DOI (Open Access)
-
Role of T lymphocytes in radiation-induced lung fibrosis-the good, the bad and the ugly!?
24. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 21. Juni 2018 - 24. Juni 2018, Leipzig,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 194 2018, Nr. 1 Supplement, Abstracts DEGRO 2018, S. 99DOI (Open Access) -
Treatment options for patients with brain metastases
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment , Jg. 41 2018, Nr. Suppl. 4, S. 20DOI (Open Access) -
Tumor Treating Fields (TTFields) in combination with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)In: Neuro-Oncology , Jg. 20 2018, Nr. suppl_3, S. iii230DOI (Open Access)
-
Vergleich der 3D-Navigation der atemabhängigen Tumor-Position mittels stereoskopischer Röntgenaufnahmen (ExacTrac) bzw. kV-ConeBeam-CTs bei der kurativen Radiotherapie von Lungenkarzinomen
23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2017 ; 14. - 18. Juni 2017, Berlin, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 193 2017, Nr. Suppl. 1: Abstracts DEGRO 2017, S. S79 – S80 -
Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl. 3, S. 307 – 308
-
Impact of tumour hypoxia and cancer stem cells on loco-regional control after primary radiochemotherapy in locally advanced HNSCC : results of a multicentre biomarker study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment , Jg. 39 2016, Nr. Suppl.1, S. 22 – 23 -
18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. S21 – S22 -
Antagonistic effect of gefitinib and cisplatin on radiation response of EGFR mutated NSCLC lines
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. 74 -
Cytotoxic Lymphocytes infiltrating tumor correlated with better Prognosis in HPV-Status-associated Patterns in Patients receiving chemotherapy adjuvant radio with Head and Neck Squamous
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. S29 – S30 -
Einfluss von Tumorvolumen und p16 Status auf die lokoregionäre Kontrolle von Kopf-Hals-Tumoren nach primärer Radiochemotherapie : Ergebnisse einer multizentrischen Biomarker-Studie des Deutschen Konsortiums für Translationale Krebsforschung (DKTK-ROG)
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. S31 – S32 -
Einzelnukleotid Polymorphismen in Reparaturproteinen sind prognoserelevant für des Überleben von Kopf-Hals-Tumorpatienten nach postoperativer Radiochemotherapie mit Cisplatin (DKTK-ROG)
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl. 1 , S. 28 - S. 29 -
Ganzhirnbestrahlung (WBRT) versus Ganzhirnbestrahlung mit bildgeführter stereotaktischer Bestrahlung multipler cerebraler Metastasen mittels helikaler Tomotherapie – Toxizitätsanalyse einer randomisierten Studie
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. 149 -
Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl. 1, S. 36 – 37 -
Identification of epigenetic prognosticators of adjuvant radiochemotherapy in HPV-negative squamous cell carcinomas of the head and neck (SCCHN) via genome-wide methylation analysis : A multicenter biomarker study of the German Cancer Consortium Radiation
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. 31 -
Intensitätsmodulierte Radiotherapie (IMRT) und simultane Chemotherapie für Patienten mit Nasopharyxkarzinom – monozentrische, retrospektive Studie
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl. 1, S. 120 -
Loss or therapeutic inhibition of extracellular adenosine production by ecto-5 -nucleotidase (CD73) attenuates radiation-induced lung fibrosis
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. 14 – S15 -
Loss or therapeutic inhibition of extracellular adenosine production by ecto-5 -nucleotidase(CD73) attenuates radiation-induced lung fibrosis
European Cancer Congress (ECC 2015), 25.-29.09.2015, Wien,In: European Journal of Cancer (EJC) , Jg. 51 2015, Nr. Supplement 3, S. S117 – S118 -
Modulation of chromatin structure and its effect on radiation induced DNA damage signaling and survival
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl.1, S. S77 – S78 -
Next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck (LASCCHN) for assessment of mutational patterns and their interference with outcome after adjuvant chemoradiation : Results from a multicenter biomarker study of t
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,In: Oncology Research and Treatment , Jg. 38 2015, Nr. Suppl.5, S. 176 -
Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 191 2015, Nr. Suppl. 1, S. 23 -
TNM-classification for clear cell sarcomas - is it useful?
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,In: Oncology Research and Treatment , Jg. 38 2015, Nr. Suppl. 5, S. 247 – 248 -
Chk2-Expression in Squamous cell carcinoma of the Oral cavity, Oropharynx and Hypopharynx as a Prognostic factor for the Long-term survival after definitive Radiochemotherapy
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl.1, S. 86 -
DVH-Parameters and Toxicity of a dose increased Chemotherapy in locally advanced Squamous Cell Carcinoma (uT3/T4) of the Esophagus - Results of a prospective Phase I/II Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl.1, S. 109 -
Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
56th Annual Meeting of the American Society for Radiation Oncology ; 14-17 September 2014, San Francisco, CA, USA,In: International Journal of Radiation Oncology, Biology, Physics , Jg. 90 2014, Nr. 1, Supplement, S. S146 – S147 -
Definitive Radio Chemo Therapy for locally advanced Squamous Cell Carcinoma (uT3/T4) of the Esophagus with increased dose Radiation Therapy - Results of a Phase I/II Study (SPOT)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl.1, S. 36 – 37 -
Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl. 1, S. 5 – 6 -
Mesenchymale Stammzell-Therapie zur Radioprotektion des Lungen-Gewebes
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl. 1, S. 15 -
Neoadjuvant Docetaxel/Cisplatin/5-FU based radiochemotherapy (RT-CT) increases pathologic complete remissions and survival of patients with locally advanced oral cavity carcinomas in comparison to RT-CT with cisplatin alone followed by resection : a long term observational study
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment , Jg. 37 2014, Nr. Suppl.1, S. 79 -
Neoadjuvante Radiochemotherapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Vergleich der Langzeitergebnisse zweier Protokolle
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl.1, S. 99 – 100 -
Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl 1, S. 17 -
Radiation induced DNA damage sensing in the context of histone methylation
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl.1, S. 78 -
Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+FoxP3+regulatory T cells
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 03.-06.07.2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl.1: Abstract-Band DEGRO 2014, S. 59 – 60 -
Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 190 2014, Nr. Suppl. 1, S. 17 -
Whole thorax irradiation initiates a local and systemic accumulation of immunosuppressive FoxP3+regulatory T cells
23rd Biennial Congress of the European Association for Cancer Research, 05.–08.07.2014, München,In: European Journal of Cancer (EJC) , Jg. 50 2014, Nr. Suppl. 5, S. S223 -
Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 19 -
Akzelerierte Post-Pneumonektomie Salvage-Bestrahlung (RTx) mit simultaner Chemotherapie (CTx) bei Patienten mit kontralateralen zentralen Lungenkarzinomrezidiven
DEGRO 2013 19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 67 -
Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : lassen sich Patienten lieber operieren?
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 87 -
Vergleich einer neoadjuvanten Radiochemotherapie mit Docetaxel/Cisplatin/5-FU oder mit Cisplatin alleine beim lokal fortgeschrittenen Mundhöhlenkarzinom
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 189 2013, Nr. Suppl. 1, S. 100 -
1118 Potential Role of Lymphocytes During DNA Damage-induced PneumopathyIn: European Journal of Cancer (EJC) , Jg. 48 2012, Nr. Suppl. 5, S. S269
-
Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy
54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, MA, USA,In: International Journal of Radiation Oncology, Biology, Physics , Jg. 84 2012, Nr. 3, Supplement, S. S154 -
Einfluss der Induktions-Chemotherapie auf die Parameter der hochdosierten Radiochemotherapie beim lokal fortgeschrittenen LungenkarzinomIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 96
-
Lymphocytes play a role in radiation-induced pneumopathyIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. Suppl.1: Abstract-Band DEGRO 2014, S. 126 – 127
-
Neoadjuvante Therapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Induktionschemotherapie mit Docetaxel/Cisplatin/5-FU gefolgt von simultaner Strahlentherapie plus Docetaxel/Cisplatin gefolgt von OP – Phase-I-Studie: Ergebnisse und 3J-FUIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 188 2012, Nr. 1 Suppl., S. 90 – 90
-
Postpneumonectomy Radical Accelerated (Re-)irradiation and Concurrent Chemotherapy for Patients With Contralateral Central Lung Cancer Relapses
54th Annual Meeting of the American Society for Radiation Oncology ; 28-31 October 2012, Boston, USA,In: International Journal of Radiation Oncology, Biology, Physics , Jg. 84 2012, Nr. 3, Supplement, S. S598 -
Acute Side Effects of Combined HDR Brachytherapy/3D conformal external beam Radiotherapy in Comparison to radical Prostatectomy for Prostate Cancer with Risk Factors
DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 114 – 115 -
Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,In: Journal of Thoracic Oncology , Jg. 6 2011, Nr. 6, Suppl. 2, S. S376 – S377 -
Helical tomotherapy of soft tissue sarcoma-optimized soft-tissue preservation also acral Tumors
DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 17 – 17 -
Ist der maximale Standardized Glucose Uptake Value (SUVmax) im 18F-FDG-PET/CT vor Beginn der definitiven Radiochemotherapie bei lokal fortgeschrittenen Tumoren im Kopf-Halsbereich mit Langzeit-Überlebensdaten assoziiert?
DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 25 – 25 -
Protonentherapie bei der Bestrahlung von Patienten mit Prostatakarzinom unter Einschluss des pelvinen Lymphabflusses : eine Planvergleichsstudie
DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 61 – 62 -
Re-Radiotherapie bei Patienten mit einem Tumorrezidiv bzw. Zweitkarzinom im Kopfhalsbereich
DEGRO 2011, 17. Jahreskongress der Deutschen Gesellschaft für Radioonkologie, 2. bis 5. Juni 2011, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 187 2011, Nr. Suppl. 1, S. 28 -
Bildnavigierte Präzisions-Strahlentherapie mittels helikaler Tomotherapie erlaubt eine Salvage-Strahlentherapie im Rezidiv nach Vorbestrahlung
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 85 – 85 -
Dosisgesteigerte Strahlentherapie nach PET/CT-Planung in Kombination mit Induktions- und Simultaner Chemotherapie bei lokal fortgeschrittenen Platten-epithelkarzinomen (uT3/T4) des Ösophagus : Ergebnisse einer Phase I/II Studie (SPOT)
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 48 -
Ganzhirnbestrahlung mit integriertem Boost für Patienten mit multiplen Hirnmetastasen
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 49 – 50 -
Intensitätsmodulierte Protonentherapie für Patienten mit supratentoriell lokalisierten anaplastischen Gliomen – eine Planvergleichsstudie
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 54 – 54 -
Patienten-Lagekontrolle während einer Tomotherapie-Fraktion mit Hilfe eines 3D-Kamerasystems – Erste Erfahrungen
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 83 – 83 -
Re-Bestrahlung von Tumorrezidiven im Kopfhalsbereich mittels helikaler Tomotherapie
16. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Radioonkologie • Medizinische Physik • Strahlenbiologie Magdeburg, 3. bis 6. Juni 2010,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 186 2010, Nr. Suppl. 1, S. 132 -
Role of apoptosis and tissue factor expression in the increased thrombogenicity of human glioma cell lines after ionizing radiation
77th Annual Meeting, March 30 – April 1, 2011, Frankfurt a. M., Germany,In: Naunyn-Schmiedeberg's Archives of Pharmacology , Jg. 381 2010, Nr. Suppl. 1, S. 59 – 60 -
Altered fractionation schemes in radiotherapyIn: Controversies in the Treatment of Lung Cancer / 12th International Symposium on Special Aspects of Radiotherapy, Berlin, October 2008 / Heide, Jürgen (Hrsg.) , Jg. 42 2010, S. 150 – 156
-
Oligometastatic non-small cell lung cancer : Impact of local and systemic treatment approaches on clinical outcome
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology , Jg. 34 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S828 -
Ergebnisse der stereotaktischen Radiochirurgie mit anschließender Resektion bei großen intraokularen Aderhautmelanomen im Stadium IIA-IIIB mit hohem Risiko : eine prospektive Registerstudie
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S132DOI (Open Access) -
Evaluierung der KI-Segmentierungssoftware MIMContour ProtégéAITM im Thorax-Bauch-Bereich
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S68DOI (Open Access) -
Immuntherapie eines Mikrosatelliten-instabilen metastasierten Talgdrüsenkarzinoms der Glandula submandibularis mit Pembrolizumab
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment , Jg. 45 2022, Nr. Supplement 2, S. 230 – 231DOI (Open Access) -
Klinisch-dosimetrische Aspekte der Online-Planadaptation bei der kurativen Strahlentherapie lokal begrenzter urogenitaler Tumore : erste Erfahrungen mit dem Ethos®- System
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S71 – S72DOI (Open Access) -
MRT-morphologische Charakteristika von niedrig malignen, orbitalen Non-Hodgkin Lymphomen nach kurativ intendierter Strahlentherapie : Bildgebende Remissionskriterien in der Langzeitbeobachtung
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S129DOI (Open Access) -
Tägliche anatomische Deformationen und Dosisdeviationen der online-onboard IGRT-basierten Navigation des ETHOS™ LINAC in IMRT/VMAT für Kopf-Halstumore
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S88DOI (Open Access) -
Verbesserte Hippocampus-Schonung durch non-koplanare Techniken im Vergleich zu koplanaren Techniken bei der Strahlentherapie von Gliomen
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 198 2022, Nr. Supplement 1, S. S80DOI (Open Access) -
Efficacy of immunotherapy (IO) and subsequent systemic treatment after failure of IO in patients with recurrent or metastatic head and neck cancer in a real-world setting
ESMO Congress 2021, 16 – 21 September 2021, Virtual,In: Annals of Oncology , Jg. 32 2021, Nr. Suppl. 5, S. S812DOI (Open Access) -
Modification of total nodal Irradiation (TNI) as Part of Conditioning prior to allogeneic Stem Cell Transplantation (aSCT) for hematological Diseases using helical Tomotherapy or IMRT based on a retrospective Cohort
27. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, DEGRO 2021, virtuell,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 197 2021, Nr. Suppl. 1: Abstracts DEGRO 2021, S. S173DOI (Open Access) -
Modifikation der total nodalen Bestrahlung (TNI) als Teil der Konditionierung vor allogener Stammzelltransplantation (aSZT) bei hämatologischen Erkrankungen mittels helikaler Tomotherapie anhand einer retrospektiven Kohorte
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics , Jg. 196 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S105DOI (Open Access)